Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lovell, 2012, Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis., Clin Gastroenterol Hepatol, 10, 712, 10.1016/j.cgh.2012.02.029
Longstreth, 2006, Functional bowel disorders., Gastroenterology, 130, 1480, 10.1053/j.gastro.2005.11.061
Mayer, 2001, Depression, anxiety, and the gastrointestinal system., J Clin Psychiatry, 62, 28
Akehurst, 2002, Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting., Pharmacoeconomics, 20, 455, 10.2165/00019053-200220070-00003
Frank, 2002, Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases., Clin Ther, 24, 675, 10.1016/S0149-2918(02)85143-8
Gralnek, 2000, The impact of irritable bowel syndrome on health-related quality of life., Gastroenterology, 119, 654, 10.1053/gast.2000.16484
Seres, 2008, Different associations of health related quality of life with pain, psychological distress and coping strategies in patients with irritable bowel syndrome and inflammatory bowel disorder., J Clin Psychol Med Settings, 15, 287, 10.1007/s10880-008-9132-9
Drossman, 1993, U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact., Dig Dis Sci, 38, 1569, 10.1007/BF01303162
DiBonaventura, 2011, Health-related quality of life, work productivity and health care resource use associated with constipation predominant irritable bowel syndrome., Curr Med Res Opin, 27, 2213, 10.1185/03007995.2011.623157
Andreasson, 2003, PRP11 The validity of the work productivity and activity impairment questionnaire for patients with asthma (WPAIASTHMA): results from a web-based study., Value Health, 6, 780, 10.1016/S1098-3015(10)61986-9
Reilly, 2003, Validation of the dermatology life quality index and the work productivity and activity impairment-chronic hand dermatitis questionnaire in chronic hand dermatitis., J Am Acad Dermatol, 48, 128, 10.1067/mjd.2003.128
Kobelt, 2003, Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia., BJU Int, 91, 190, 10.1046/j.1464-410X.2003.04062.x
Silk, 2001, Impact of irritable bowel syndrome on personal relationships and working practices., Eur J Gastroenterol Hepatol, 13, 1327, 10.1097/00042737-200111000-00011
Drossman, 2009, A focus group assessment of patient perspectives on irritable bowel syndrome and illness severity., Dig Dis Sci, 54, 1532, 10.1007/s10620-009-0792-6
Bjorkman, 2014, The gendered impact of Irritable Bowel Syndrome: a qualitative study of patients experiences., J Adv Nurs, 70, 1334, 10.1111/jan.12294
Farndale, 2011, Long-term impact of irritable bowel syndrome: a qualitative study., Prim Health Care Res Dev, 12, 52, 10.1017/S1463423610000095
Ung, 2013, How patients with long-term experience of living with irritable bowel syndrome manage illness in daily life: a qualitative study., Eur J Gastroenterol Hepatol, 25, 1478, 10.1097/MEG.0b013e328365abd3
Reilly, 2004, The validity and accuracy of the Work Productivity and Activity Impairment questionnaire-irritable bowel syndrome version (WPAI:IBS)., Aliment Pharmacol Ther, 20, 459, 10.1111/j.1365-2036.2004.02091.x
Ringstrom, 2013, Structured patient education for patients with irritable bowel syndrome (ibs-school) improves symptoms and quality of life also in clinical practice., U Eur Gastroenterol J, 1, A50
Bennet, 2016, Global cytokine profiles and association with clinical characteristics in patients with irritable bowel syndrome., Am J Gastroenterol, 111, 1165, 10.1038/ajg.2016.223
Wahlqvist, 2002, Validity of a work productivity and activity impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD)-results from a cross-sectional study., Value Health, 5, 106, 10.1046/j.1524-4733.2002.52101.x
Francis, 1997, The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress., Aliment Pharmacol Ther, 11, 395, 10.1046/j.1365-2036.1997.142318000.x
Labus, 2004, The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale., Aliment Pharmacol Ther, 20, 89, 10.1111/j.1365-2036.2004.02007.x
Hahn, 1997, Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome., Aliment Pharmacol Ther, 11, 547, 10.1046/j.1365-2036.1997.00168.x
Zigmond, 1983, The hospital anxiety and depression scale., Acta Psychiatr Scand, 67, 361, 10.1111/j.1600-0447.1983.tb09716.x
Smets, 1995, The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue., J Psychosom Res, 39, 315, 10.1016/0022-3999(94)00125-O
Kroenke, 2002, The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms., Psychosom Med, 64, 258, 10.1097/00006842-200203000-00008
Hakanson, 2009, Struggling with an unfamiliar and unreliable body: the experience of irritable bowel syndrome., J Nurs Healthc Chronic Illn, 1, 29, 10.1111/j.1365-2702.2008.01001.x
Frandemark, 2017, Fatigue: a distressing symptom for patients with irritable bowel syndrome., Neurogastroenterol Motil, 29, e12898, 10.1111/nmo.12898
Hellstrom, 2011, Characteristics of acute pain attacks in patients with irritable bowel syndrome meeting Rome III criteria., Am J Gastroenterol, 106, 1299, 10.1038/ajg.2011.78
Niemyjska, 2015, Evaluation Of Irritable Bowel Syndrome Symptoms Amongst Warsaw University Students., Pol Przegl Chir, 87, 252, 10.1515/pjs-2015-0050
Kanazawa, 2016, Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBSC): a large population-based Internet survey in Japan., Biopsychosoc Med, 10, 19, 10.1186/s13030-016-0070-8
Huang, 2012, PGI31 Impact of treatment response on health utilities and work productivity among patients with irritable bowel syndrome with constipation: pooled results from phase iii clinical trials., Value Health, 15, A331, 10.1016/j.jval.2012.08.780
Reilly, 2005, Effect of tegaserod on work and daily activity in irritable bowel syndrome with constipation., Aliment Pharmacol Ther, 22, 373, 10.1111/j.1365-2036.2005.02577.x
Tack, 2005, A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation., Gut, 54, 1707, 10.1136/gut.2005.070789
Buono, 2014, Impact of linaclotide treatment on work productivity and activity impairment in adults with irritable bowel syndrome with constipation: results from 2 randomized, double-blind, placebo-controlled phase 3 trials., Am Health Drug Benefits, 7, 289
Cremonini, 2012, Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS., Aliment Pharmacol Ther, 36, 437, 10.1111/j.1365-2036.2012.05208.x
Eswaran, 2017, A diet low in fermentable oligo-, di-, and monosaccharides and polyols improves quality of life and reduces activity impairment in patients with irritable bowel syndrome and diarrhea., Clin Gastroenterol Hepatol, 15, 1890, 10.1016/j.cgh.2017.06.044
Creed, 2003, The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome., Gastroenterology, 124, 303, 10.1053/gast.2003.50055
McCrone, 2008, Cost-effectiveness of cognitive behaviour therapy in addition to mebeverine for irritable bowel syndrome., Eur J Gastroenterol Hepatol, 20, 255, 10.1097/MEG.0b013e3282f2519d
Andersson, 2011, Cost-effectiveness of internet-based cognitive behavior therapy for irritable bowel syndrome: results from a randomized controlled trial., BMC Public Health, 11, 215, 10.1186/1471-2458-11-215
Buono, 2017, Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea., Health Qual Life Outcomes, 15, 35, 10.1186/s12955-017-0611-2